98 related articles for article (PubMed ID: 15492819)
21. Zonula occludens-1 (ZO-1) redistribution is involved in the regulation of cell dissociation in pancreatic cancer cells.
Tan X; Egami H; Ishikawa S; Kurizaki T; Hirota M; Ogawa M
Dig Dis Sci; 2005 Aug; 50(8):1402-9. PubMed ID: 16110828
[TBL] [Abstract][Full Text] [Related]
22. Paclitaxel and ceramide synergistically induce cell death with transient activation of EGFR and ERK pathway in pancreatic cancer cells.
Qiu L; Zhou C; Sun Y; Di W; Scheffler E; Healey S; Wanebo H; Kouttab N; Chu W; Wan Y
Oncol Rep; 2006 Oct; 16(4):907-13. PubMed ID: 16969513
[TBL] [Abstract][Full Text] [Related]
23. Src tyrosine kinase inhibitor PP2 suppresses ERK1/2 activation and epidermal growth factor receptor transactivation by X-irradiation.
Li Z; Hosoi Y; Cai K; Tanno Y; Matsumoto Y; Enomoto A; Morita A; Nakagawa K; Miyagawa K
Biochem Biophys Res Commun; 2006 Mar; 341(2):363-8. PubMed ID: 16414009
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation.
Luppi F; Longo AM; de Boer WI; Rabe KF; Hiemstra PS
Lung Cancer; 2007 Apr; 56(1):25-33. PubMed ID: 17175059
[TBL] [Abstract][Full Text] [Related]
25. Epidermal growth factor receptor is involved in clusterin-induced astrocyte proliferation.
Shim YJ; Shin YJ; Jeong SY; Kang SW; Kim BM; Park IS; Min BH
Neuroreport; 2009 Mar; 20(4):435-9. PubMed ID: 19218870
[TBL] [Abstract][Full Text] [Related]
26. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells.
Johnson FM; Saigal B; Donato NJ
J Cell Physiol; 2005 Nov; 205(2):218-27. PubMed ID: 15887238
[TBL] [Abstract][Full Text] [Related]
27. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
[TBL] [Abstract][Full Text] [Related]
28. Unique role of SNT-2/FRS2beta/FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways.
Huang L; Watanabe M; Chikamori M; Kido Y; Yamamoto T; Shibuya M; Gotoh N; Tsuchida N
Oncogene; 2006 Oct; 25(49):6457-66. PubMed ID: 16702953
[TBL] [Abstract][Full Text] [Related]
29. Signal transduction pathway of the induction of cell motility in hamster pancreatic ductal adenocarcinoma cell.
Akagi J; Egami H; Kurizaki T; Ohmachi H; Ogawa M
Invasion Metastasis; 1997; 17(1):16-25. PubMed ID: 9425321
[TBL] [Abstract][Full Text] [Related]
30. Plasmin-induced smooth muscle cell proliferation requires epidermal growth factor activation through an extracellular pathway.
Roztocil E; Nicholl SM; Galaria II; Davies MG
Surgery; 2005 Aug; 138(2):180-6. PubMed ID: 16153425
[TBL] [Abstract][Full Text] [Related]
31. Differential regulation of ERK1/2 and p38(MAPK) by components of the Rho signaling pathway during sphingosine-1-phosphate-induced smooth muscle cell migration.
Galaria II; Fegley AJ; Nicholl SM; Roztocil E; Davies MG
J Surg Res; 2004 Dec; 122(2):173-9. PubMed ID: 15555614
[TBL] [Abstract][Full Text] [Related]
32. Effects of antisense epidermal growth factor and its receptor retroviral expression vectors on cell growth of human pancreatic carcinoma cell line.
Liu T; Chen J; Zeng C
Chin Med J (Engl); 1995 Sep; 108(9):653-9. PubMed ID: 8575229
[TBL] [Abstract][Full Text] [Related]
33. Investigation of the Mek-MAP kinase-Rsk pathway in human breast cancer.
Salh B; Marotta A; Matthewson C; Ahluwalia M; Flint J; Owen D; Pelech S
Anticancer Res; 1999; 19(1B):731-40. PubMed ID: 10216485
[TBL] [Abstract][Full Text] [Related]
34. Epidermal growth factor receptor-regulated human bladder cancer motility is in part a phosphatidylinositol 3-kinase-mediated process.
Theodorescu D; Laderoute KR; Gulding KM
Cell Growth Differ; 1998 Nov; 9(11):919-28. PubMed ID: 9831244
[TBL] [Abstract][Full Text] [Related]
35. Metastin and its variant forms suppress migration of pancreatic cancer cells.
Masui T; Doi R; Mori T; Toyoda E; Koizumi M; Kami K; Ito D; Peiper SC; Broach JR; Oishi S; Niida A; Fujii N; Imamura M
Biochem Biophys Res Commun; 2004 Feb; 315(1):85-92. PubMed ID: 15013429
[TBL] [Abstract][Full Text] [Related]
36. Epidermal growth factor receptor expression in human pancreatic cancer: Significance for liver metastasis.
Tobita K; Kijima H; Dowaki S; Kashiwagi H; Ohtani Y; Oida Y; Yamazaki H; Nakamura M; Ueyama Y; Tanaka M; Inokuchi S; Makuuchi H
Int J Mol Med; 2003 Mar; 11(3):305-9. PubMed ID: 12579331
[TBL] [Abstract][Full Text] [Related]
37. Positive regulation of Raf1-MEK1/2-ERK1/2 signaling by protein serine/threonine phosphatase 2A holoenzymes.
Adams DG; Coffee RL; Zhang H; Pelech S; Strack S; Wadzinski BE
J Biol Chem; 2005 Dec; 280(52):42644-54. PubMed ID: 16239230
[TBL] [Abstract][Full Text] [Related]
38. ROS mediated EGFR/MEK/ERK/HIF-1α Loop Regulates Glucose metabolism in pancreatic cancer.
Wang G; Li Y; Yang Z; Xu W; Yang Y; Tan X
Biochem Biophys Res Commun; 2018 Jun; 500(4):873-878. PubMed ID: 29702094
[TBL] [Abstract][Full Text] [Related]
39. Cloning of a variant epidermal growth factor receptor.
Moriai T; Kobrin MS; Korc M
Biochem Biophys Res Commun; 1993 Mar; 191(3):1034-9. PubMed ID: 8466482
[TBL] [Abstract][Full Text] [Related]
40. MEK1/2 overactivation can promote growth arrest by mediating ERK1/2-dependent phosphorylation of p70S6K.
Guégan JP; Ezan F; Gailhouste L; Langouët S; Baffet G
J Cell Physiol; 2014 Jul; 229(7):903-15. PubMed ID: 24501087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
